{"id":"https://openalex.org/W4282966412","doi":"https://doi.org/10.1158/1538-7445.am2022-3107","title":"Abstract 3107: Identifying therapeutic vulnerabilities in HR-positive, HER2-negative advanced breast cancer patient-derived xenograft models refractory to CDK4/6 inhibition","display_name":"Abstract 3107: Identifying therapeutic vulnerabilities in HR-positive, HER2-negative advanced breast cancer patient-derived xenograft models refractory to CDK4/6 inhibition","publication_year":2022,"publication_date":"2022-06-15","ids":{"openalex":"https://openalex.org/W4282966412","doi":"https://doi.org/10.1158/1538-7445.am2022-3107"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2022-3107","doi":"https://doi.org/10.1158/1538-7445.am2022-3107","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2022-3107","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5026936750","display_name":"Nicole M. Kettner","orcid":"https://orcid.org/0000-0003-2043-4407","observed_orcids":["https://orcid.org/0000-0003-2043-4407"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nicole M. Kettner","raw_affiliation_strings":["1UT MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1UT MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017644527","display_name":"Juliana Navarro-Yepes","orcid":"https://orcid.org/0000-0003-0393-3773","observed_orcids":["https://orcid.org/0000-0003-0393-3773"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Juliana Navarro-Yepes","raw_affiliation_strings":["1UT MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1UT MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000113218","display_name":"Tuyen N. Bui","orcid":"https://orcid.org/0000-0001-8509-3653","observed_orcids":["https://orcid.org/0000-0001-8509-3653"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Tuyen N. Bui","raw_affiliation_strings":["1UT MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1UT MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077700916","display_name":"Xiayu Rao","orcid":"https://orcid.org/0000-0001-5245-7449","observed_orcids":["https://orcid.org/0000-0001-5245-7449"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Xiayu Rao","raw_affiliation_strings":["1UT MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1UT MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100378341","display_name":"Jing Wang","orcid":"https://orcid.org/0000-0002-5398-0802","observed_orcids":["https://orcid.org/0000-0002-5398-0802","https://orcid.org/0009-0006-4171-5397","https://orcid.org/0000-0002-8911-9555","https://orcid.org/0009-0003-0661-5954"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jing Wang","raw_affiliation_strings":["1UT MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1UT MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076426660","display_name":"Funda Meric\u2010Bernstam","orcid":"https://orcid.org/0000-0001-6816-6072","observed_orcids":["https://orcid.org/0000-0001-6816-6072"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Funda Meric-Bernstam","raw_affiliation_strings":["1UT MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1UT MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017411324","display_name":"Kelly K. Hunt","orcid":"https://orcid.org/0000-0001-9156-8723","observed_orcids":["https://orcid.org/0000-0001-9156-8723"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kelly K. Hunt","raw_affiliation_strings":["1UT MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1UT MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110083321","display_name":"Debu Tripathy","orcid":"https://orcid.org/0000-0002-5711-2404","observed_orcids":["https://orcid.org/0000-0002-5711-2404"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Debu Tripathy","raw_affiliation_strings":["1UT MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1UT MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5042960706","display_name":"Khandan Keyomarsi","orcid":"https://orcid.org/0000-0002-5440-0849","observed_orcids":["https://orcid.org/0000-0002-5440-0849"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Khandan Keyomarsi","raw_affiliation_strings":["1UT MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1UT MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I1343551460"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"82","issue":"12_Supplement","first_page":"3107","last_page":"3107"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12829","display_name":"Advanced Breast Cancer Therapies","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12829","display_name":"Advanced Breast Cancer Therapies","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11914","display_name":"PARP inhibition in cancer therapy","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/hr-her2-breast-cancer","display_name":"hormone receptor-positive HER2-negative breast cancer","score":0.8769999742507935},{"id":"https://openalex.org/keywords/cdk4-6-inhibitor-resistance","display_name":"CDK4/6 inhibitor resistance","score":0.890999972820282},{"id":"https://openalex.org/keywords/palbociclib","display_name":"palbociclib","score":0.9959999918937683},{"id":"https://openalex.org/keywords/patient-derived-xenografts","display_name":"patient-derived xenografts","score":0.8889999985694885},{"id":"https://openalex.org/keywords/intrinsic-resistance","display_name":"intrinsic resistance","score":0.9049999713897705},{"id":"https://openalex.org/keywords/acquired-resistance","display_name":"acquired resistance","score":0.9990000128746033},{"id":"https://openalex.org/keywords/endocrine-therapy","display_name":"endocrine therapy","score":0.8330000042915344},{"id":"https://openalex.org/keywords/therapeutic-vulnerabilities","display_name":"therapeutic vulnerabilities","score":0.75},{"id":"https://openalex.org/keywords/differentially-expressed-genes","display_name":"differentially expressed genes","score":0.8840000033378601},{"id":"https://openalex.org/keywords/gene-expression-signatures","display_name":"gene expression signatures","score":0.8610000014305115},{"id":"https://openalex.org/keywords/resistance-biomarkers","display_name":"resistance biomarkers","score":0.7059999704360962},{"id":"https://openalex.org/keywords/actionable-therapeutic-targets","display_name":"actionable targets","score":0.6179999709129333},{"id":"https://openalex.org/keywords/endocrine-resistance","display_name":"endocrine therapy resistance","score":0.40299999713897705}],"concepts":[{"id":"https://openalex.org/C2779744173","wikidata":"https://www.wikidata.org/wiki/Q15269707","display_name":"Palbociclib","level":5,"score":0.9632027745246887},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5906327962875366},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5755027532577515},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.5639753341674805},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.5455191135406494},{"id":"https://openalex.org/C2994294914","wikidata":"https://www.wikidata.org/wiki/Q1645075","display_name":"Acquired resistance","level":3,"score":0.512115478515625},{"id":"https://openalex.org/C162317418","wikidata":"https://www.wikidata.org/wiki/Q252857","display_name":"Transcriptome","level":4,"score":0.4779129922389984},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.45474550127983093},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4485996663570404},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.3444492518901825},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.305772066116333},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.26771748065948486},{"id":"https://openalex.org/C150194340","wikidata":"https://www.wikidata.org/wiki/Q26972","display_name":"Gene expression","level":3,"score":0.2527391016483307},{"id":"https://openalex.org/C2775930923","wikidata":"https://www.wikidata.org/wiki/Q12859063","display_name":"Metastatic breast cancer","level":4,"score":0.22119620442390442},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.09911522269248962}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2022-3107","doi":"https://doi.org/10.1158/1538-7445.am2022-3107","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2022-3107","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9940000176429749}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W7132871786","https://openalex.org/W3012961610","https://openalex.org/W2885048539","https://openalex.org/W4408445370","https://openalex.org/W2765815443","https://openalex.org/W7219332133","https://openalex.org/W4322771947","https://openalex.org/W3027216332","https://openalex.org/W4390952294","https://openalex.org/W2740647924"],"abstract_inverted_index":{"Abstract":[0],"Background:":[1],"Clinically,":[2],"the":[3,44,85,93,146,185,212,233,236,321],"addition":[4],"of":[5,17,46,87,96,114,171,184,228,271,320],"CDK4/6":[6,52,97,315],"inhibitors":[7],"(e.g.":[8],"palbociclib)":[9],"to":[10,51,60,76,81,91,196,215,235,254,276,314],"endocrine":[11],"therapy":[12],"(ET)":[13],"significantly":[14],"delays":[15],"progression":[16,159],"advanced":[18,307],"hormone":[19],"receptor-positive":[20],"(HR+),":[21],"HER2-negative":[22,306],"(HER2-)":[23],"breast":[24,308],"cancer":[25,309],"patients.":[26],"However,":[27],"most":[28],"patients":[29,65,130],"develop":[30],"resistance":[31,80,115,151,194,253,275],"and":[32,105,116,145,203,251,266,273],"progress":[33],"following":[34],"long-term":[35],"treatment.":[36],"Thus,":[37,258],"an":[38,57],"ongoing":[39,260],"clinical":[40],"challenge":[41],"has":[42],"been":[43],"identification":[45],"biomarkers":[47,75],"that":[48,109],"predict":[49,77],"response":[50,78],"inhibitors.":[53],"There":[54],"is":[55],"also":[56],"unmet":[58],"need":[59],"identify":[61,92,106],"actionable":[62],"targets":[63,248],"for":[64,192,249,324],"who":[66,131,149],"have":[67,244],"progressed.":[68],"Currently,":[69],"there":[70],"are":[71,262],"no":[72],"clinically":[73],"useful":[74],"and/or":[79],"anti-CDK4/6":[82],"therapy.":[83],"Hence,":[84],"goal":[86],"our":[88,259],"study":[89],"was":[90],"therapeutic":[94,269,302],"vulnerabilities":[95,270,303],"inhibitor":[98],"resistant":[99,217,238],"patient":[100],"derived":[101],"xenograft":[102,311],"(PDX)":[103],"models":[104,187,312],"key":[107],"markers":[108],"longitudinally":[110],"correlate":[111],"with":[112,138,157],"development":[113],"inform":[117],"new":[118],"treatment":[119,137,256],"directions.":[120],"Methods:":[121],"We":[122,199],"obtained":[123],"4":[124],"different":[125,189],"PDX":[126,186,218],"models,":[127],"two":[128,148],"from":[129],"progressed":[132],"after":[133],"2-4":[134],"months":[135,162],"on":[136,164],"palbociclib":[139,165],"plus":[140,166],"ET":[141],"(i.e.":[142,154],"intrinsic":[143,193,216,237,250,272],"resistance)":[144,156],"other":[147],"developed":[150],"over":[152],"time":[153],"acquired":[155,197,213,252,274],"disease":[158],"between":[160],"12-18":[161],"while":[163],"ET.":[167],"To":[168],"elucidate":[169],"mechanisms":[170],"resistance,":[172],"we":[173],"performed":[174],"genome-wide":[175],"expression":[176],"analysis":[177,224],"via":[178],"RNA-sequencing.":[179],"Results:":[180],"The":[181],"molecular":[182],"assessment":[183],"revealed":[188,226],"transcriptomic":[190],"signatures":[191],"compared":[195,214],"resistance.":[198],"identified":[200,245],"3,386":[201],"upregulated":[202],"2,829":[204],"downregulated":[205],"significant":[206],"differentially":[207],"expressed":[208],"genes":[209],"(DEGs)":[210],"in":[211,232,304],"models.":[219,239],"Further,":[220],"gene":[221],"set":[222],"enrichment":[223,227],"(GSEA)":[225],"distinct":[229,268],"driver":[230],"pathways":[231],"acquired-compared":[234],"Conclusions:":[240],"Collectively,":[241],"these":[242],"results":[243],"potential":[246],"unique":[247],"guide":[255],"strategies.":[257],"studies":[261],"geared":[263],"towards":[264],"identifying":[265],"targeting":[267],"palbociclib.":[277],"Citation":[278],"Format:":[279],"Nicole":[280],"M.":[281],"Kettner,":[282],"Juliana":[283],"Navarro-Yepes,":[284],"Tuyen":[285],"N.":[286],"Bui,":[287],"Xiayu":[288],"Rao,":[289],"Jing":[290],"Wang,":[291],"Funda":[292],"Meric-Bernstam,":[293],"Kelly":[294],"K.":[295],"Hunt,":[296],"Debu":[297],"Tripathy,":[298],"Khandan":[299],"Keyomarsi.":[300],"Identifying":[301],"HR-positive,":[305],"patient-derived":[310],"refractory":[313],"inhibition":[316],"[abstract].":[317],"In:":[318],"Proceedings":[319],"American":[322],"Association":[323],"Cancer":[325,336],"Research":[326],"Annual":[327],"Meeting":[328],"2022;":[329],"2022":[330],"Apr":[331],"8-13.":[332],"Philadelphia":[333],"(PA):":[334],"AACR;":[335],"Res":[337],"2022;82(12_Suppl):Abstract":[338],"nr":[339],"3107.":[340]},"counts_by_year":[],"updated_date":"2026-10-16T09:59:22.235173","created_date":"2022-06-17T00:00:00"}